ADARx Pharmaceuticals, Inc. (ADRX)
ADARx Pharmaceuticals, Inc. (ADRX) Insider Trading
Directors, officers and holders of more than 10% of ADRX report their trades in its stock on SEC Form 4, within two business days. Each row below is one Form 4 transaction line. The one-letter code says what kind of transaction it was: only P (purchase) and S (sale) are open-market or private trades; awards, option exercises, tax withholding and gifts carry other codes.
Recent Form 4 transactions
The 47 most recent of 47 transactions on file: 6 with code P, 0 with code S and 41 with other codes.
| Date | Insider | Title | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 28, 2026 | LAV Biosciences Fund V, L.P. | 10% Owner | C Conversion | 360,577 | Not measured | Not measured |
| Sep 28, 2026 | SR ONE CAPITAL MANAGEMENT, LLC | 10% Owner | C Conversion | 1,113,666 | Not measured | Not measured |
| Sep 28, 2026 | SR ONE CAPITAL MANAGEMENT, LLC | 10% Owner | C Conversion | 512,897 | Not measured | Not measured |
| Sep 28, 2026 | SR ONE CAPITAL MANAGEMENT, LLC | 10% Owner | P Purchase | 592,593 | $17.00 | $10,074,081 |
| Sep 28, 2026 | SR ONE CAPITAL MANAGEMENT, LLC | 10% Owner | C Conversion | 1,538,691 | Not measured | Not measured |
| Sep 28, 2026 | SR ONE CAPITAL MANAGEMENT, LLC | 10% Owner | P Purchase | 414,814 | $17.00 | $7,051,838 |
| Sep 28, 2026 | SR ONE CAPITAL MANAGEMENT, LLC | 10% Owner | C Conversion | 1,667,468 | Not measured | Not measured |
| Sep 28, 2026 | SR ONE CAPITAL MANAGEMENT, LLC | 10% Owner | C Conversion | 169,001 | Not measured | Not measured |
| Sep 28, 2026 | SR ONE CAPITAL MANAGEMENT, LLC | 10% Owner | P Purchase | 592,593 | $17.00 | $10,074,081 |
| Sep 28, 2026 | George Simeon | Director | C Conversion | 3,334,938 | Not measured | Not measured |
| Sep 28, 2026 | George Simeon | Director | C Conversion | 1,113,666 | Not measured | Not measured |
| Sep 28, 2026 | George Simeon | Director | C Conversion | 512,897 | Not measured | Not measured |
| Sep 28, 2026 | George Simeon | Director | P Purchase | 592,593 | $17.00 | $10,074,081 |
| Sep 28, 2026 | George Simeon | Director | C Conversion | 1,538,691 | Not measured | Not measured |
| Sep 28, 2026 | George Simeon | Director | P Purchase | 414,814 | $17.00 | $7,051,838 |
| Sep 28, 2026 | George Simeon | Director | C Conversion | 1,667,468 | Not measured | Not measured |
| Sep 28, 2026 | George Simeon | Director | C Conversion | 169,001 | Not measured | Not measured |
| Sep 28, 2026 | George Simeon | Director | P Purchase | 592,593 | $17.00 | $10,074,081 |
| Sep 28, 2026 | LAV Biosciences Fund V, L.P. | 10% Owner | C Conversion | 8,908,775 | Not measured | Not measured |
| Sep 28, 2026 | LAV Biosciences Fund V, L.P. | 10% Owner | C Conversion | 1,667,469 | Not measured | Not measured |
| Sep 28, 2026 | LAV Biosciences Fund V, L.P. | 10% Owner | C Conversion | 513,067 | Not measured | Not measured |
| Sep 28, 2026 | LAV Biosciences Fund V, L.P. | 10% Owner | C Conversion | 153,868 | Not measured | Not measured |
| Sep 28, 2026 | LAV Biosciences Fund V, L.P. | 10% Owner | C Conversion | 307,738 | Not measured | Not measured |
| Sep 28, 2026 | LAV Biosciences Fund V, L.P. | 10% Owner | C Conversion | 307,738 | Not measured | Not measured |
| Sep 28, 2026 | LAV Biosciences Fund V, L.P. | 10% Owner | C Conversion | 1,953,774 | Not measured | Not measured |
| Sep 28, 2026 | LAV Biosciences Fund V, L.P. | 10% Owner | C Conversion | 601,161 | Not measured | Not measured |
| Sep 28, 2026 | LAV Biosciences Fund V, L.P. | 10% Owner | C Conversion | 180,288 | Not measured | Not measured |
| Sep 28, 2026 | LAV Biosciences Fund V, L.P. | 10% Owner | C Conversion | 360,577 | Not measured | Not measured |
| Sep 28, 2026 | SR ONE CAPITAL MANAGEMENT, LLC | 10% Owner | C Conversion | 3,334,938 | Not measured | Not measured |
| Sep 28, 2026 | SR ONE CAPITAL MANAGEMENT, LLC | 10% Owner | C Conversion | 3,907,547 | Not measured | Not measured |
| Sep 28, 2026 | SR ONE CAPITAL MANAGEMENT, LLC | 10% Owner | C Conversion | 1,304,883 | Not measured | Not measured |
| Sep 28, 2026 | SR ONE CAPITAL MANAGEMENT, LLC | 10% Owner | C Conversion | 600,962 | Not measured | Not measured |
| Sep 28, 2026 | SR ONE CAPITAL MANAGEMENT, LLC | 10% Owner | C Conversion | 1,802,885 | Not measured | Not measured |
| Sep 28, 2026 | SR ONE CAPITAL MANAGEMENT, LLC | 10% Owner | C Conversion | 1,953,773 | Not measured | Not measured |
| Sep 28, 2026 | SR ONE CAPITAL MANAGEMENT, LLC | 10% Owner | C Conversion | 198,019 | Not measured | Not measured |
| Sep 28, 2026 | George Simeon | Director | C Conversion | 3,907,547 | Not measured | Not measured |
| Sep 28, 2026 | George Simeon | Director | C Conversion | 1,304,883 | Not measured | Not measured |
| Sep 28, 2026 | George Simeon | Director | C Conversion | 600,962 | Not measured | Not measured |
| Sep 28, 2026 | George Simeon | Director | C Conversion | 1,802,885 | Not measured | Not measured |
| Sep 28, 2026 | George Simeon | Director | C Conversion | 1,953,773 | Not measured | Not measured |
| Sep 28, 2026 | George Simeon | Director | C Conversion | 198,019 | Not measured | Not measured |
| Sep 28, 2026 | LAV Biosciences Fund V, L.P. | 10% Owner | C Conversion | 10,438,412 | Not measured | Not measured |
| Sep 24, 2026 | MacLeod Alan Robert | Chief Scientific Officer | A Award | 170,692 | Not measured | Not measured |
| Sep 24, 2026 | Fisk Ryan | CFO and CBO | A Award | 170,692 | Not measured | Not measured |
| Sep 24, 2026 | Li Zhen | President and CEO | A Award | 1,024,152 | Not measured | Not measured |
| Sep 24, 2026 | Ackles Robert William | Chief People Officer | A Award | 85,346 | Not measured | Not measured |
| Sep 24, 2026 | Zhu Rui (NMN) | Chief Technology Officer | A Award | 512,076 | Not measured | Not measured |
Questions about this data
Which insider transactions are open-market trades?
Code P (open market or private purchase) and code S (open market or private sale). Code F is shares withheld to pay tax on vesting stock, A is an award from the company, M and X are option exercises and G is a gift. None of those is the insider choosing to buy or sell in the market.
How quickly are insider trades reported?
A Form 4 is due before the end of the second business day after the trade. The date shown is the transaction date from the form.
Who has to file Form 4?
Officers, directors and beneficial owners of more than 10% of a class of the company’s registered equity, under Section 16 of the Securities Exchange Act.
Look up any code in the Form 4 transaction code reference, or read Form 4 codes explained.